Sanjul Patel, MD
Internal Medicine · Middleburg Heights, OHNPI 1538785233
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 230 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,512, more than ten times the $121 reported in 2021. Among internal medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$603
- AbbVie$503
- Pfizer$407
- Bayer$292
- Novo Nordisk$290
- Lilly USA, LLC$274
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,733100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $603 |
| AbbVie | 19 | $503 |
| Pfizer | 25 | $407 |
| Bayer | 12 | $292 |
| Novo Nordisk | 17 | $290 |
| Lilly USA, LLC | 16 | $274 |
| Olympus America Inc. | 2 | $270 |
| Novartis | 12 | $243 |
| Otsuka America Pharmaceutical, Inc. | 8 | $201 |
| Boehringer Ingelheim | 11 | $181 |
| GSK | 12 | $180 |
| Johnson & Johnson | 7 | $142 |
| Exact Sciences | 7 | $128 |
| E.r. Squibb & Sons, L.L.C. | 7 | $126 |
| Inspire Medical Systems, Inc. | 2 | $121 |
| Sumitomo Pharma America, Inc. | 6 | $116 |
| Dexcom, Inc. | 6 | $109 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $105 |
| Astellas Pharma US Inc | 4 | $77 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Amgen | 2 | $35 |
| Mylan Specialty L.p. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| CSL Behring | 1 | $32 |
| Merck | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $25 |
| Soleno Therapeutics, Inc. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Mannkind Corporation | 1 | $20 |
| Viatris Specialty LLC | 1 | $16 |
| Antares Pharma, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iTIND System$270
- UBRELVY$121
How this compares
$4,733 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 136 | $71,289 |
| OzempicSemaglutide | 36 | $39,678 |
| XifaxanRifaximin | 11 | $31,321 |
| OtezlaApremilast | 13 | $28,113 |
| FarxigaDapagliflozin Propanediol | 58 | $27,039 |
| JardianceEmpagliflozin | 41 | $23,863 |
| XareltoRivaroxaban | 46 | $16,248 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $10,221 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $8,253 |
| MyrbetriqMirabegron | 28 | $6,458 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 25 | $5,282 |
| EntrestoSacubitril/Valsartan | 14 | $5,202 |
| JanuviaSitagliptin Phosphate | 12 | $5,180 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,174 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $4,554 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $407 | $71,289136 claims |
| Novo NordiskOzempic | $290 | $39,67836 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $603 | $35,29269 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $105 | $31,32111 claims |
| AmgenOtezla | $35 | $28,11313 claims |
| Boehringer IngelheimJardiance, Tradjenta | $181 | $27,54955 claims |
| Johnson & JohnsonXarelto | $142 | $16,24846 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $180 | $15,39424 claims |
| Astellas Pharma US IncMyrbetriq | $77 | $6,45828 claims |
| NovartisEntresto | $243 | $5,20214 claims |
| MerckJanuvia | $32 | $5,18012 claims |
| AbbVieSynthroid | $503 | $1,59422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in Middleburg Heights
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.